MedTrace Logo

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

NCT00513916 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-12-19

No results posted yet for this study

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. Eating a diet high in isoflavones, compounds found in soy foods, may keep cancer from forming.

PURPOSE: This randomized phase III trial is studying the effects of dietary soy on estrogens in breast fluid, blood, and urine samples from healthy women.

Conditions

Interventions

DIETARY_SUPPLEMENT

soy isoflavones

High or low dose of soy isoflavones in the diet.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Hawaii Cancer Research Center

    lead OTHER

Principal Investigators

  • Gertraud Maskarinec, MD, PhD · University of Hawaii Cancer Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2011-02-28
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00513916 on ClinicalTrials.gov